Daniel J Moore Selected Research

Daniel J Moore Research Topics

Disease

17	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2022 - 04/2002
8	Inflammation (Inflammations) 10/2021 - 08/2008
5	Hyperglycemia 01/2022 - 01/2013
3	Diabetes Mellitus 12/2021 - 03/2012
3	Human Influenza (Influenza) 05/2008 - 01/2003
2	Neoplasms (Cancer) 10/2021 - 06/2006
2	Hypertension (High Blood Pressure) 01/2021 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 10/2010
2	Insulin Resistance 01/2020 - 01/2019
2	Sepsis (Septicemia) 11/2018 - 08/2015
1	Pregnancy Complications 01/2022
1	Chronic Disease (Chronic Diseases) 12/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021
1	Lymphoma (Lymphomas) 01/2020
1	Congenital Hypothyroidism (Cretinism) 01/2020
1	Hyperinsulinism (Hyperinsulinemia) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Mason-Type Diabetes 01/2019
1	Colitis 01/2018
1	Necrotizing Enterocolitis 01/2018
1	Atrophy 10/2016
1	Acute Lung Injury 01/2014
1	Shock 01/2014
1	Pneumonia (Pneumonitis) 01/2014
1	Infertility (Sterility) 08/2013
1	Ciliopathies 08/2013
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 08/2013
1	Hyperlipidemias (Hyperlipidemia) 04/2013
1	Hypercholesterolemia 04/2013
1	Fatty Liver 04/2013
1	Body Weight (Weight, Body) 04/2013
1	Atherosclerosis 04/2013
1	Wounds and Injuries (Trauma) 04/2013
1	Ischemia 04/2013
1	Hyperthyroidism 11/2011
1	Infections 06/2011
1	Blindness (Hysterical Blindness) 10/2010
1	Opportunistic Infections (Opportunistic Infection) 06/2006
1	Myocarditis (Carditis) 12/2003

Drug/Important Bio-Agent (IBA)

7	Insulin (Novolin)FDA Link 01/2021 - 08/2008
4	AntigensIBA 01/2021 - 05/2008
3	AutoantibodiesIBA 01/2022 - 01/2019
3	CytokinesIBA 10/2016 - 10/2010
3	Hemagglutinins (Hemagglutinin)IBA 05/2008 - 01/2003
2	Immunoglobulins (Immunoglobulin)IBA 11/2022 - 04/2002
2	Immunoglobulin M (IgM)IBA 11/2022 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2019
2	Blood Glucose (Blood Sugar)IBA 12/2021 - 04/2013
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2018
2	EndotoxinsIBA 08/2015 - 01/2014
2	ChemokinesIBA 01/2014 - 10/2010
2	cSN50.1 peptideIBA 01/2014 - 04/2013
1	pentaglobulinIBA 11/2022
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	AutoantigensIBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	pembrolizumabIBA 01/2020
1	IodineIBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	GlucokinaseIBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 11/2018
1	Biological ProductsIBA 11/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2016
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2014
1	LipopolysaccharidesIBA 01/2014
1	Virulence Factors (Pathogenicity Factors)IBA 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Karyopherins (Importin)IBA 01/2014
1	Cell-Penetrating PeptidesIBA 01/2014
1	Dyneins (Dynein)IBA 08/2013
1	ElementsIBA 08/2013
1	Triglycerides (Triacylglycerol)IBA 04/2013
1	LDL Receptors (LDL Receptor)IBA 04/2013
1	Transcription Factors (Transcription Factor)IBA 04/2013
1	NF-kappa B (NF-kB)IBA 04/2013
1	Dihydrotachysterol (AT 10)IBA 01/2013
1	AntibodiesIBA 11/2011
1	SolutionsIBA 08/2008
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2008
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2006
1	Ventricular MyosinsIBA 12/2003
1	CC ChemokinesIBA 12/2003
1	Peptides (Polypeptides)IBA 01/2003

Therapy/Procedure

8	Therapeutics 10/2021 - 06/2006
2	Immunotherapy 01/2020 - 10/2010
2	Transplantation 04/2013 - 08/2008
2	Islets of Langerhans Transplantation 08/2008 - 06/2004
1	Heart Transplantation (Grafting, Heart) 11/2016
1	Hematopoietic Stem Cell Transplantation 03/2012
1	Organ Transplantation 06/2006